Skip to content
SynthioLabs logo

SynthioLabs

SynthioLabs is a YC Spring 2025 (P25) company. Based in San Francisco, CA, USA. Team of 8.

  • Artificial Intelligence
  • Biotech
  • Healthcare
  • Enterprise

About SynthioLabs

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

SynthioLabs builds a voice AI platform for pharmaceutical and life sciences commercial teams, automating engagement with healthcare professionals and patients around the clock. Its suite of specialized agents handles HCP outreach, patient support, field team assistance, and on-demand market research simulations. The platform replaces manual field rep calls, live call center interactions, and ad hoc research workflows that pharma commercial operations currently run through human labor.

Business model

Book-a-demo sales motion suggests enterprise contracts, though specific pricing terms are not published.

Go-to-market

Pharma and life sciences commercial teams are the buyers; sales-led acquisition through direct demos, with named agent products targeting distinct roles such as field reps, HCP engagement managers, and patient support teams.

From the Y Combinator listing

How SynthioLabs describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Reimagining Pharma Customer Engagement with AI Agents

A conversational AI platform built for life sciences extending field reach, enabling 24/7 compliant engagement, and scaling trusted conversations with HCPs and patients.

Facts

Industry
Healthcare / Healthcare
Location
San Francisco, CA, USA
Team size
8
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works